维普期刊资源整合服务平台（V6.5）

79篇 您的检索式：作者名="CHAPUIS N"

选中清除导出查看参考文献查看引证文献引用追踪共4页首页上一页第1页下一页末页 /4 跳转

	题名	作者	年代	出处	被引量
1	Perspectives on inhibiting mTOR as a future treatment strategy for hematological malignancies显示文摘	Chapuis N Tamburini J Green AS		0，，：	1
2	IkappaB kinase overcomes PI3K/Akt and ERK/MAPK to control FOXO3a activity in acute myeloid leukemia 显示文摘	Chapuis N Park S Leotoing L	2010	Blood2010，116，20：	1
3	P1 - 103, a dual inhibitor of class IA phosphatidylinositide 3 - kinase and mTOR, has antileukemic activity in AML显示文摘	Park S Chapuis N Bardet V	2008	Leukemia2008，22，9：	1
4	PI-103, a dual inhibitor ofClass IA phosphatidylinositide 3-kinase and mTOR, has antileu-kemic activity in AML显示文摘	Park S Chapuis N Bardet V	2008	Leukemia2008，22，9：	1
5	Role of PI3K/AKT and roTOR signaling pathways in acute rnyeloid leukemia显示文摘	Park S Chapuis N Tamburini J	2010	Haema- tologica2010，95，5：	1
6	LKB1/AMPK/ mTOR signaling pathway in hematological malignancies: from metabolism to cancer cell biology显示文摘	Green AS Chapuis N Lacombe C	2011	Celt Cycle2011，10，13：	1
7	Mammalian target of rapamycin(mTOR) inhibition activates phosphatidylinositol 3-kinase/Akt by up-regulating insulin-like growth factor- I receptor signaling in acute myeloid leukemia: Rationale for therapeutic inhibition of both pathways显示文摘	Tamburini J Chapuis N Bardet V	2008	Blood2008，111，：	1
8	PI3K and roTOR si gnaling pathways in cancer z new data on targeted therapies 显示文摘	Willems L Tamburini J Chapuis N	2012	Curr Oncol Rep2012，14，2：	1
9	The LKB1/AMPK signaling pathway has tumor suppressor activity in acute myeloid leukemia through the repression of mTOR-dependent oncogenic mRNA translation显示文摘	Green AS Chapuis N Maciel TT		0，，：	1
10	IkappaB kinase overcomes PI3K/Akt and ERK/MAPK to control FOXO3a activity in acute myeloid leukemia显示文摘	Chapuis N Park S Leotoing L	2010	Blood2010，116，20：	1
11	Role of the PI3K/ AKT and roTOR signaling pathways in acute myeloid leuke- mia 显示文摘	Park S Chapuis N Tamburini J	2010	Haematologiea2010，95，5：	1
12	The dual mTORCl andmTORC2 inhibitor AZD8055 has anti - tumor activity in acute mye-loid leukemia显示文摘	Willems L Chapuis N Puissant A	2011	Leukemia2011，12，：	1
13	LKB1/AMPK/mTOR signaling pathway in hematological malignancies: from metabolism to cancer cell biology 显示文摘	Green AS Chapuis N Lacombe C	2011	Cell Cycle2011，10，13：	1
14	Targeting translation in acute myeloid leukemia: a new paradigm for therapy? 显示文摘	TAMBURINI J GREEN A S CHAPUIS N	2009	Cell Cycle2009，8，23：	1
15	Mammalian target of ra- pamycin (mTOR) inhibition activates phosphatidylinositol 3 -ki- nase/Akt by up - regulating insulin - like growth factor - 1 recep- tor signaling in acute myeloid leukemia: rationale for therapeutic inhibition of both pathways 显示文摘	Tamburini J Chapuis N Bardet V	2008	Blood2008，111，1：	1
16	The dual mTORC1 and mTORC2 inhibitor AZD8055 has anti-tumor :tivity in acute myeloid leukemia显示文摘	WILLEMS L CHAPUIS N PUISSANT A	2012	Leukemia2012，26，6：	1
17	IκB kinase overcomes PI3K/Akt and ERK/MAPK to control FOXO3a activity in acute myeloid leukemia显示文摘	Chapuis N Park S Leotoing L	2010	{H}Blood2010，，20：	1
18	IKB kinase overcomes PI3 KI Akt and ERKIMAPK to control FOX03a activity in acute myeloid leukemia显示文摘	Chapuis N Park S Leotoing L	2010	J Blood2010，116，42：	1
19	Flow cytometric detectionof dyserythropoiesis: a sensitive and powerful diagnostic toot formyelodysplastic syndromes显示文摘	Mathis S Chapuis N Debord C	2013	Leukemia2013，27，10：	1
20	Dual inhibition of PI3K and mTORC1/2 signaling by NVP-BEZ235 as a new therapeutic strategy for acute myeloid leukemia 显示文摘	CHAPUIS N TAMBURINI J GREEN AS	2010	Clin Cancer Res2010，16，22：	1

返回顶部每页显示：

共4页首页上一页第1页下一页末页 /4 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示